The Global Mild Cognitive Impairment Market Size is expected to reach USD 3.5 Billion by 2032, at a CAGR of 5.24% during the forecast period 2022 to 2032. Some medical conditions, such as high blood pressure, diabetes, and heart disease, can increase the risk of mild cognitive impairment market.